274 related articles for article (PubMed ID: 10593801)
1. Chronic glucocorticoid therapy-induced osteoporosis in patients with obstructive lung disease.
Goldstein MF; Fallon JJ; Harning R
Chest; 1999 Dec; 116(6):1733-49. PubMed ID: 10593801
[TBL] [Abstract][Full Text] [Related]
2. Evidence-based guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: a consensus document of the Belgian Bone Club.
Devogelaer JP; Goemaere S; Boonen S; Body JJ; Kaufman JM; Reginster JY; Rozenberg S; Boutsen Y
Osteoporos Int; 2006 Jan; 17(1):8-19. PubMed ID: 16217586
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men.
Cruse LM; Valeriano J; Vasey FB; Carter JD
J Clin Rheumatol; 2006 Oct; 12(5):221-5. PubMed ID: 17023807
[TBL] [Abstract][Full Text] [Related]
4. Practice patterns in patients at risk for glucocorticoid-induced osteoporosis.
Feldstein AC; Elmer PJ; Nichols GA; Herson M
Osteoporos Int; 2005 Dec; 16(12):2168-74. PubMed ID: 16142501
[TBL] [Abstract][Full Text] [Related]
5. The pathogenesis, epidemiology and management of glucocorticoid-induced osteoporosis.
van Staa TP
Calcif Tissue Int; 2006 Sep; 79(3):129-37. PubMed ID: 16969593
[TBL] [Abstract][Full Text] [Related]
6. A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update.
Eastell R; Reid DM; Compston J; Cooper C; Fogelman I; Francis RM; Hosking DJ; Purdie DW; Ralston SH; Reeve J; Russell RG; Stevenson JC; Torgerson DJ
J Intern Med; 1998 Oct; 244(4):271-92. PubMed ID: 9797491
[TBL] [Abstract][Full Text] [Related]
7. Five year study of etidronate and/or calcium as prevention and treatment for osteoporosis and fractures in patients with asthma receiving long term oral and/or inhaled glucocorticoids.
Campbell IA; Douglas JG; Francis RM; Prescott RJ; Reid DM;
Thorax; 2004 Sep; 59(9):761-8. PubMed ID: 15333852
[TBL] [Abstract][Full Text] [Related]
8. Etidronate and glucocorticoid induced osteoporosis.
Ortego-Centeno N; Muñoz-Torres M; Callejas-Rubio JL; Riera-Montes M
J Rheumatol; 2005 Jan; 32(1):199-200. PubMed ID: 15630758
[No Abstract] [Full Text] [Related]
9. [Secondary osteoporosis. Evidence of treatment efficacy in patients with glucocorticoid-induced osteoporosis].
Sato S
Clin Calcium; 2007 Apr; 17(4):600-5. PubMed ID: 17404491
[TBL] [Abstract][Full Text] [Related]
10. What is new in the treatment of steroid-induced osteoporosis?
Liu RH; Werth VP
Semin Cutan Med Surg; 2007 Dec; 26(4):203-9. PubMed ID: 18395668
[TBL] [Abstract][Full Text] [Related]
11. Prevention of glucocorticoid-induced osteoporosis.
Saag KG
South Med J; 2004 Jun; 97(6):555-8. PubMed ID: 15255421
[TBL] [Abstract][Full Text] [Related]
12. [Glucocorticoid-induced osteoporosis and rheumatic diseases. Pathogenesis, prevention and treatment].
Di Munno O; Delle Sedie A
Reumatismo; 2006; 58(1):11-21. PubMed ID: 16639483
[TBL] [Abstract][Full Text] [Related]
13. Asthma and chronic obstructive airway diseases are associated with osteoporosis and fractures: a literature review.
Smith BJ; Phillips PJ; Heller RF
Respirology; 1999 Jun; 4(2):101-9. PubMed ID: 10382227
[TBL] [Abstract][Full Text] [Related]
14. [Management of osteoporosis in patients with inhaled glucocorticoids].
Wada S; Kamiya S; Fukawa T
Clin Calcium; 2006 Nov; 16(11):1871-77. PubMed ID: 17079855
[TBL] [Abstract][Full Text] [Related]
15. In whom and how to prevent glucocorticoid-induced osteoporosis.
Adachi JD; Papaioannou A
Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):1039-64. PubMed ID: 16301196
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid-induced osteoporosis management among seniors, by year, sex, and indication, 1996-2012.
Albaum JM; Lévesque LE; Gershon AS; Liu G; Cadarette SM
Osteoporos Int; 2015 Dec; 26(12):2845-52. PubMed ID: 26138581
[TBL] [Abstract][Full Text] [Related]
17. Alendronate for the prevention of bone loss in patients on inhaled steroid therapy.
Lau EM; Woo J; Chan YH; Li M
Bone; 2001 Dec; 29(6):506-10. PubMed ID: 11728919
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoid-induced osteoporosis: pathogenesis and management.
Nishimura J; Ikuyama S
J Bone Miner Metab; 2000; 18(6):350-2. PubMed ID: 11052469
[TBL] [Abstract][Full Text] [Related]
19. A cost effectiveness analysis of calcium and vitamin D supplementation, etidronate, and alendronate in the prevention of vertebral fractures in women treated with glucocorticoids.
Buckley LM; Hillner BE
J Rheumatol; 2003 Jan; 30(1):132-8. PubMed ID: 12508402
[TBL] [Abstract][Full Text] [Related]
20. Effect on bone turnover markers of once-yearly intravenous infusion of zoledronic acid versus daily oral risedronate in patients treated with glucocorticoids.
Devogelaer JP; Sambrook P; Reid DM; Goemaere S; Ish-Shalom S; Collette J; Su G; Bucci-Rechtweg C; Papanastasiou P; Reginster JY
Rheumatology (Oxford); 2013 Jun; 52(6):1058-69. PubMed ID: 23365149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
